New nanoparticles deliver high doses antibiotics directly into bacteria

New nanoparticles deliver high doses of antibiotics directly into bacteria

6:36 AM, 9th May 2012
New nanoparticles deliver high doses of antibiotics directly into bacteria
Nanoparticles (green), targeting bacteria (red).

CAMBRIDGE, US: Over the past several decades, scientists have faced challenges in developing new antibiotics even as bacteria have become increasingly resistant to existing drugs. One strategy that might combat such resistance would be to overwhelm bacterial defenses by using highly targeted nanoparticles to deliver large doses of existing antibiotics. Researchers at MIT and Brigham and Women’s Hospital have developed a nanoparticle designed to evade the immune system and home in on infection sites, then unleash a focused antibiotic attack.

This approach would mitigate the side effects of some antibiotics and protect the beneficial bacteria that normally live inside our bodies, said Aleks Radovic-Moreno, Graduate Student, MIT. Robert Langer, Professor, MIT and Omid Farokzhad, Director of Nanomedicine and Biomaterials Laboratory, Brigham and Women’s Hospital are senior authors of the paper describing the particles in the journal ACS Nano.

The team created the new nanoparticles from a polymer capped with polyethylene glycol (PEG), which is commonly used for drug delivery because it is nontoxic and can help nanoparticles travel through the bloodstream by evading detection by the immune system. Their next step was to induce the particles to specifically target bacteria.

Researchers have previously tried to target particles to bacteria by giving them a positive charge, which attracts them to bacteria’s negatively charged cell walls. However, the immune system tends to clear positively charged nanoparticles from the body before they can encounter bacteria.

To overcome this, the researchers designed antibiotic-carrying nanoparticles that can switch their charge depending on their environment. While they circulate in the bloodstream, the particles have a slight negative charge. However, when they encounter an infection site, the particles gain a positive charge, allowing them to tightly bind to bacteria and release their drug payload.

This switch is provoked by the slightly acidic environment surrounding bacteria. Infection sites can be slightly more acidic than normal body tissue if disease-causing bacteria are reproducing rapidly, deplete oxygen. Lack of oxygen triggers a change in bacterial metabolism, leading them to produce organic acids. Cells called neutrophils in body produce acids as they try to consume the bacteria. Just below the outer PEG layer, the nanoparticles contain a pH-sensitive layer made of long chains of the amino acid histidine. As pH drops from 7 to 6, the polyhistidine molecule tends to gain protons, giving the molecule a positive charge.

Once the nanoparticles bind to bacteria, they begin releasing their drug payload, which is embedded in the core of the particle. In this study, the researchers designed the particles to deliver vancomycin, used to treat drug-resistant infections, but the particles could be modified to deliver other antibiotics or combinations of drugs. Many antibiotics lose their effectiveness as acidity increases, but the researchers found that antibiotics carried by nanoparticles retained their potency better than traditional antibiotics in an acidic environment.

The researchers are studying how much this might limit the effectiveness of their nanoparticle delivery. They are also conducting studies in animals to determine whether the particles will remain pH-sensitive in the body and circulate for long enough to reach their targets.

© MIT News

0 Comments

Login

Your Comments (Up to 2000 characters)
Please respect our community and the integrity of its participants. WOC reserves the right to moderate and approve your comment.

Related News


H B Fuller sells Central American paints business to Grupo Mundial

ST PAUL, US: H B Fuller Company has signed an agreement to sell its Central American paints business to Compania Global de Pinturas, a company of Grup ...

Read more
K+S to sell nitrogen fertilizer unit to EuroChem

KASSEL, GERMANY/MOSCOW, RUSSIA: K+S Aktiengesellschaft has signed an agreement with EuroChem regarding the sale of K+S Nitrogen, one of the leading su ...

Read more
Foster Wheeler bags Shell’s contract for downstream projects in Asia

ZUG, SWITZERLAND: Foster Wheeler’s Global Engineering and Construction subsidiary has signed an Asian Enterprise Framework agreement (EFA) with ...

Read more
UK allocates $97 million for carbon capture in emerging markets

LONDON, UK: The United Kingdom allocated 60 million pounds ($97 million) to encourage the development of carbon capture and storage (CCS) technology i ...

Read more
Airgas names Molinini as President and CEO

RADNOR, US: Airgas appointed Michael L Molinini as President and Chief Executive Officer effective immediately. Molinini will succeed Peter McCausland ...

Read more
Momentive introduces SilTRUST transparent silicone encapsulant material

ALBANY, US: Momentive introduced its SilTRUST transparent silicone encapsulant material, a new transparent silicone encapsulant technology that ensure ...

Read more